Forgotten metabolic side effects of diuretics: Lipids, glucose and vitamin B1 (thiamin) metabolism;Vergessene metabolische nebenwirkungen der diuretika: Lipid-, glukose- und vitamin B1- stoffwechsel

Praxis

Volumn 93, Issue 20, 2004, Pages 857-863

  Suter, P M ^a  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

Diuretics; Glucose; Lipids; Side effects; Thiamine; Vitamin B1

Indexed keywords

EID: 80051672431     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.93.20.857     Document Type: Review

References (45)

1. Schwandt P. The importance of reaching lipid targets: statins and the prevention of atherosclerosis. Int J Clin Pract. 2003; 57: 396-404. (Pubitemid 36798449)
2. Suter PM, Vetter W. Metabolic effects of antihypertensive drugs. J Hypertens. 1995; 13 (Suppl.4): S11-S17. (Pubitemid 26015747)
3. Meier P. Paracelsus : Arzt und Prophet : Annaherungen an Theophrastus von Hohenheim Zurich: Pendo Verlag (Pendo Pocket; 8); 1998.
4. Hulley SB, Furberg CD, Gurland B, al. e. SHEP: antihypertensive efficacy of chlorthalidone. Am J Cardiol. 1985; 56: 913-920.
5. SHEP-Cooperative-Research-Group. Prevention of Stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final Results of the systolic hypertension in the elderly program (SHEP). JAMA. 1991; 265: 3255-3264.
6. Unwin RJ, Ligueros M, Shakelton C, Wilcox CS. Diuretics in the management of hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York (N.Y.): Raven Press Ltd.; 1995: 2785-2799.
7. Freis ED. The efficacy and safety of diuretics in treating hypertension. Ann Intern Med. 1995; 122: 223-226.
8. Schmidt MI,Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism. 1996; 45: 699-706. (Pubitemid 26176111)
9. Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med. 2003; 115 (Suppl 8A): 24S-28S.
10. Law MR,Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003; 326: 1427-1432.
11. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J. 2004; 147: 106-112. (Pubitemid 38037405)
12. Denke MA, Sempos CT, Grundy SM. Excess body weight: An under-recognized contributor to dyslipidemia in white American Women. Arch Intern Med. 1994; 154: 401-410. (Pubitemid 24072213)
13. .Wattigney WA, Harsha DW, Srinivasan SR,Webber LS, Berenson GS. Increasing impact of obesity on serum lipids and lipoproteins in young adults. The Bogalusa Heart Study. Arch Int Med. 1991; 151: 2017-2022.
14. Guidelines-Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003; 21: 1011-1053.
15. Joint National Committee on Prevention Diagnosis, Evaluation,and Treatment of High Blood Pressure. National Heart,Lung,and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206-1252.
16. Suter PM, Hasler E, Vetter W. Hypertonie und Koronare Herzkrankheit. Globale Risikomodulation durch Kontrolle des Korpergewichtes. Schweiz Med Runschau (PRAXIS). 1996; 85: 113-116. (Pubitemid 126587521)
17. MacMahon S, Peto R, Cutler J, al e. Blood pressure, stroke, and coronary artery disease (Part 1). Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution. Lancet. 1990; 335: 765-774. (Pubitemid 20106689)
18. Krum H, Skiba M, Gilbert RE. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy. Diabet Med. 2003; 20: 708-712. (Pubitemid 41701462)
19. Tannen RL. Hypo-hyperkalaemia. In: Davison AM, Cameron JS, Grunfeld J-P, Kerr DNS, Ritz E, Winearls CG, eds. Oxford Textbook of Clinical Nephrology. Vol. 1. Oxford (GB): Oxford University Press; 1998: 201-224.
20. Tsuji H, Venditti FJ, Evans JC, Larson MG, Levy D. The association of levels of serum potassium and magnesium with ventricular prematue complexes (The Framingham Heart Study). Am J Cardiol. 1994; 74: 232-235. (Pubitemid 24239043)
21. Norris W, Kunzelman KS, Bussell S, Rohweder L, Cochran RP. Potassium Supplementation, Diet vs Pills: A Randomized Trial in Postoperative Cardiac Surgery Patients. Chest. 2004; 125.
22. Greenberg A. Diuretic complications. Am J Med Sci. 2000; 319: 10-24. (Pubitemid 30367871)
23. Morrow LE, Grimsley EW. Long-term diuretic therapy in hypertensive patients: effects on serum homocysteine, vitamin B6, vitamin B12, and red blood cell folate concentrations. South Med J. 1999; 92: 866-870. (Pubitemid 29446338)
24. Suter PM. Nutritional interactions: Vitamin B12, Vitamin B6 and Folate. In: Schaeverbeke J, Schaeverbeke M, eds. Biologie du vieillissement. Vieillissement cardiovasculaire et renale. Nutrition et vieillissement. Paris, France: Conferences du DEA (Troisieme Module); 1992.
25. Suter PM, Locher R, Lehmann E, Vetter W. Beziehung zwischen Homocystein und konventionellen kardiovaskularen Risikofaktoren bei ubergewichtigen Patienten. Niere und Hochdruckkrankheiten. 1994; 23: 511-512. (Pubitemid 24339561)
26. Despres JP. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome. Exerc Sport Sci Rev. 1997; 25: 271-300.
27. Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk : The Quebec cardiovascular study. Atherosclerosis. 2000; 153: 263-272. (Pubitemid 32120325)
28. Moser M, Setaro J. Continued importance of diuretics and beta-adrenergic blockers in the management of hypertension. Med Clin North Am. 2004; 88: 167-187. (Pubitemid 38165390)
29. Taylor SH. Diuretic therapy in congestive heart failure. Cardiol Rev. 2000; 8: 104-114. (Pubitemid 30152427)
30. Saito F, Kimura G. Antihypertensive mechanism of diuretics based on pressure-natriuresis relationship. Hypertension. 1996; 27: 914-918. (Pubitemid 26113839)
31. Gennari FJ. Hypokaliemia. N Engl J Med. 1998; 339: 451-458.
32. Suter PM, Haller J, Hany A, Vetter W. Diuretic Use: A Risk Factor for Subclinical Thiamine Deficiency in Elderly Patients. The Journal of Nutrition Health & Aging. 2000; 4: 69-71. (Pubitemid 30456668)
33. Leslie D, Gheorghiade M. Is there a role for thiamine supplementation in the management of heart failure. Am Heart J. 1996; 131: 1248-1250. (Pubitemid 26177020)
34. Rieck J, Halkin H, Almog S, et al. Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. J Lab Clin Med. 1999; 134: 238-243. (Pubitemid 29423096)
35. Lubetsky A, Winaver J, Seligmann H, et al. Urinary thiamine excretion in the rat: Effects of furosemide, other diuretics, and volume load. J Lab Clin Med. 1999; 134: 232-237. (Pubitemid 29423095)
36. Suter PM. Checkliste Ernahrung Stuttgart-New York: Georg Thieme Verlag; 2002.
37. Akpan T, Peschard S, Brinkane AH, Bergheul S, Leroy-Terquem E, Levy R. Right heart failure caused by thiamine deficiency (cardiac beriberi). Presse Med. 2000; 29: 240-241. (Pubitemid 30099998)
38. Gubler JC. Thiamin. In: Machlin LJ, ed. Handbook of Vitamins. Nutritional, Biochemical, and Clinical Aspects. New York, (N.Y.): Marcel Dekker Inc.; 1992: 245-297.
39. StandingCommitteeontheScientificEvaluationofDietaryReferenceIntakes. Dietary Reference Intakes for thiamin, Riboflavin, Niacin, Vitamin B6, Folte, Vitamin B12, pantothenic Acid, Biotin, and Choline Washington, DC: National Academy Press Inc.; 2000.
40. Suter PM. Alcohol: its role in health and disease. In: Baumann BB, Russell RM, eds. Present Knowledge in Nutrition.Washington, D.C.: ILSI Press; 2001: 497-507.
41. Suter PM, Russell RM. Vitamin requirements of the elderly. Am J Clin Nutr. 1987; 45: 501-512. (Pubitemid 17046204)
42. Tanphaichitr V. Thiamine. In: Rucker RB, Suttie JW, McCormick DB, Machlin LJ, eds. Handbook of Vitamins (Third Edition). New York, N.Y.: Marcel Dekker Inc.; 2001: 275-316.
43. Levy WC, Soine LA, Huth MM, Fishbein DP. Thiamine deficiency in congestive heart failure. Am J Med. 1992; 93: 705-706.
44. Shimon I, Almog S, Vered Z, et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med. 1995; 98: 485-490.
45. Cook CC, Thomson AD. B-complex vitamins in the prophylaxis and treatment of Wernicke-Korsakoff syndrome. Br J Hosp Med. 1997; 57: 461-465.